Human IgG1 Isotype Control N297A/E356D/M358L

In stock
Only %1 left
SKU
ICH2254MAEDML
Add to Compare
$306.00
Add to Wish List
More Information
Concentration 5mg/ml
isotype Human IgG1(N297A/E356D/M358L)-kappa
Host CHO Cells
Target Hen Egg Lysozyme
Specificity Human IgG1 with a N297A/E356D/M358L mutation
Purification Method This monoclonal antibody was purified using Protein A
Formulation Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity >95% by SDS-PAGE
Endotoxin ≤ 1.0 EU/mg as determined by the LAL method
Storage This antibody is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications Functional Assays
Application Notes This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Write Your Own Review
You're reviewing:Human IgG1 Isotype Control N297A/E356D/M358L
Your Rating
Who Viewed This Also Viewed
Anti-Mouse TNFR2 (TR75-54.7) In Vivo Antibody - Low Endotoxin
Anti-Mouse TNFR2 (TR75-54.7) In Vivo Antibody - Low Endotoxin
$390.00 - $2,885.00
Bulk Anti-Human CD3 (UCHT-1) Antibody
Bulk Anti-Human CD3 (UCHT-1) Antibody
$390.00 - $2,885.00
Tiragolumab Biosimilar - Research Grade
Tiragolumab Biosimilar - Research Grade
$306.00 - $19,500.00
Sabatolimab Biosimilar - Research Grade
Sabatolimab Biosimilar - Research Grade
$306.00 - $19,500.00
VHH - Human Fc Isotype Control
VHH - Human Fc Isotype Control
$306.00 - $5,100.00
Sarilumab Biosimilar - Research Grade: PE
Sarilumab Biosimilar - Research Grade: PE
$255.00
Sacituzumab Biosimilar - Research Grade
Sacituzumab Biosimilar - Research Grade
$306.00 - $19,500.00
Retifanlimab Biosimilar - Research Grade
Retifanlimab Biosimilar - Research Grade
$732.00 - $19,500.00
Lusvertikimab Biosimilar - Research Grade
Lusvertikimab Biosimilar - Research Grade
$306.00 - $19,500.00
Bevacizumab Biosimilar - Research Grade
Bevacizumab Biosimilar - Research Grade
$306.00 - $19,500.00
Back to Top